1.3135
-0.0765 (-5.5%)
-0.0765 (-5.5%)
Upgrade to Real-Time
Market Open
| Volume | 5,145,317 |
|
|||||
| News | - | ||||||
| Day High | 1.4065 | Low High |
|||||
| Day Low | 1.27 | ||||||
Best deals to access real time data! |
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Canna Trader Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| CytoDyn Inc (QB) | CYDY | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| -0.0765 | -5.5% | 1.3135 | 13:18:57 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.39 | 1.27 | 1.4065 | 1.39 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,692 | 5,145,317 | $ 1.315 | $ 6,766,066 | - | 1.23 - 7.70 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:18:57 | 250 | $ 1.3135 | USD |
Period:
Draw Mode:
CytoDyn Inc (QB) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 819.79M | 624.13M | 377.49M | $ - | $ - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 35.77M | $ - | - | - | - |
CytoDyn (QB) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CYDY Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.38 | 1.61 | 1.27 | 1.47 | 1,719,545 | -0.0665 | -4.82% |
| 1 Month | 2.23 | 2.25 | 1.27 | 1.63 | 1,981,898 | -0.9165 | -41.1% |
| 3 Months | 1.50 | 2.54 | 1.23 | 1.63 | 2,115,906 | -0.1865 | -12.43% |
| 6 Months | 3.17 | 3.20 | 1.23 | 1.85 | 2,357,261 | -1.86 | -58.56% |
| 1 Year | 2.40 | 7.70 | 1.23 | 3.29 | 3,463,976 | -1.09 | -45.27% |
| 3 Years | 0.535 | 10.01 | 0.0552 | 3.15 | 3,057,045 | 0.7785 | 145.51% |
| 5 Years | 0.708 | 10.01 | 0.0552 | 3.03 | 1,937,825 | 0.6055 | 85.52% |
CytoDyn (QB) Description
| CytoDyn Inc. is a late-stage biotechnology company developing innovative treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor. Leronlimab is in a class of therapeutic monoclonal antibodies designed to address unmet medical needs in the areas of Human Immunodeficiency Virus (HIV), Cancer, and Immunology. |
